Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of secondary hyperparathyroidism

E Slatopolsky1, J A Delmez

  • 1Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri 63110-1093, USA.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|January 1, 1996
PubMed
Summary

Phosphorus retention in chronic kidney disease drives secondary hyperparathyroidism by increasing parathyroid hormone. Correcting phosphorus levels is crucial for vitamin D therapy to effectively manage parathyroid hormone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.

Kidney international·2007
Same author

Pathogenic mechanisms for parathyroid hyperplasia.

Kidney international. Supplement·2006
Same author

25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.

Kidney international·2006
Same author

Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.

Clinical nephrology·2006
Same author

p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.

Kidney international·2001
Same author

Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation.

The Journal of biological chemistry·2001

Area of Science:

  • Nephrology
  • Endocrinology
  • Mineral Metabolism

Background:

  • Chronic renal failure leads to parathyroid gland hyperplasia and elevated parathyroid hormone.
  • Phosphorus retention is a key factor in developing secondary hyperparathyroidism and chief cell hyperplasia.
  • Reduced renal mass in advanced kidney failure may limit 1,25-dihydroxyvitamin D3 (1,25D3) production.

Purpose of the Study:

  • To investigate the role of phosphorus in secondary hyperparathyroidism.
  • To understand the mechanisms by which phosphorus affects parathyroid hormone (PTH) synthesis and secretion.
  • To explore the impact of vitamin D metabolism abnormalities on parathyroid gland function in renal failure.

Main Methods:

  • Review of existing research on mineral metabolism in chronic renal failure.

Related Experiment Videos

  • In vivo and in vitro studies examining the effects of phosphorus on PTH.
  • Analysis of vitamin D receptor levels and their role in parathyroid hormone resistance.

    • Main Results:

    • Phosphorus directly stimulates PTH synthesis and secretion, independent of calcium and 1,25D3 levels.
    • Vitamin D metabolism is impaired, with low 1,25D3 and reduced vitamin D receptors, causing PTH resistance.
    • High pharmacological doses of 1,25D3 are needed to suppress PTH in advanced renal failure.

    Conclusions:

    • Correcting serum phosphorus is essential for effective 1,25D3 therapy in managing secondary hyperparathyroidism.
    • Monoclonal changes in parathyroid glands complicate treatment in hemodialysis patients.
    • Ongoing research focuses on the molecular mechanisms of dietary phosphorus-induced chief cell hyperplasia.